brl 44408 has been researched along with transforming growth factor beta in 1 studies
| Studies (brl 44408) | Trials (brl 44408) | Recent Studies (post-2010) (brl 44408) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 82 | 0 | 16 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenach, JC; Lavand'homme, PM | 1 |
1 other study(ies) available for brl 44408 and transforming growth factor beta
| Article | Year |
|---|---|
Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression.
Topics: Adrenergic alpha-Agonists; Animals; Behavior, Animal; Clonidine; Cytokines; Drug Combinations; Hyperalgesia; Imidazoles; Indoles; Interleukin-1; Intraoperative Care; Isoindoles; Ligation; Male; Motor Activity; Pain Threshold; Physical Stimulation; Postoperative Care; Preoperative Care; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sciatic Nerve; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Wounds and Injuries | 2003 |